GCG and obesity due to melanocortin 4 receptor deficiency: (Jorsal et al., 2018), but contradicts the observations of Osinski et al. (2021), who reported that patients with obesity and T2D have about 44% less GLP‐1 expressing cells in the jejunum than patients with obesity but without T2D.